bronchiectasis

Pidotimod is a synthetic dipeptide with immunomodulatory properties.

IA-Alkyne (Iodoacetamide-alkyne) is a TRP channel (TRPC) agonist. IA-Alkyne can be used to develop an isotopically tagged probe for quantitative cysteine-reactivity profiling. It also has the potential for the study of respiratory infection.

Etalocib (LY293111) is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities.

4-Phenyl-7,8-dihydroxycoumarin (7,8-Dihydroxy-4-phenylcoumarin) inhibits the activity of Staphylococcus aureus DNA helicase

GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 is a bioactive dipeptide that can be used for the research of bronchiectasis [1] [2].

CHF-6333 xinafoate is a neutrophil elastase (NE) inhibitor with an IC50 of 0.21 nM and a KD of 0.16 nM. It exhibits activity against both human (IC50= 0.22 nM) and rat (IC50= 3.63 nM) proteases and also inhibits proteinase 3 with an IC50 of 22 nM. This compound is applicable in bronchiectasis (BE) research.

A 68930 hydrochloride is a selective dopamine D1 receptor agonist that ameliorates Aβ1–42-induced cognitive impairment and neuroinflammation in mouse models, highlighting its relevance to Alzheimer’s disease research, and at concentrations of 10–50 μg/mL also inhibits gastric H⁺/K⁺-ATPase activity comparably to omeprazole, supporting multifunctional pharmacological investigations.

Bamifylline Hydrochloride, an adenosine A1 receptor antagonist, is uesd to treat bronchiectasis and chronic obstructive pulmonary disease.

Indimilast is used to inhibit phosphodiesterase IV that regulates lung inflammation and causes bronchiectasis by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway smooth muscle and inflammatory cells. Potential to treat chronic obst

Pibuterol Acetate is a short-acting beta-2 adrenergic receptor agonist with bronchiectasis and is used as a respiratory activated quantitative inhaler in the treatment of asthma.

Quinoline sulfate has a bronchiectasis effect on patients with asthma.

GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis.

6-Hydroxyluteolin, a flavonoid compound prepared from the above-ground parts of Salvia amarissima Ortega, inhibits aldose reductase (AR), exhibits antimicrobial activity, and can be used in the study of bronchiectasis and wet gastric diseases.

DPP1-IN-1 (compound 1) serves as a potent DPP1 inhibitor and is utilized in the study of bronchiectasis [1].

Pirbuterol acetate (Standard) is the standard substance of Pirbuterol acetate, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Pibuterol Acetate is a short-acting beta-2 adrenergic receptor agonist with bronchiectasis and is used as a respiratory activated quantitative inhaler in the treatment of asthma.